Trauma remains the leading cause of death with bleeding as the primary cause of preventable mortality. When death occurs it happens quickly, typically within the first 6 hours after injury.
Introduction
Trauma is the leading cause of death world-wide in persons under the age of 40 years (1) and accounts for approximately 10% of all deaths in general (2) . Despite substantial improvements in acute trauma care, uncontrolled haemorrhage is still responsible for more than 50% of all trauma-related deaths in both civilian and military settings within the first 48 hours after hospital admission (3) . Haemorrhage has also been determined to be the most common cause of preventable deaths (4) (5) (6) . Clinical observations together with recent research emphasize the central role of coagulopathy in acute civilian and military trauma care (7) (8) (9) (10) (11) (12) (13) (14) (15) but rapid identification of patients with active ongoing bleeding requiring transfusion or even massive transfusion (MT) remains unsatisfactory. Vice-versa, the early identification of trauma patients at risk for ongoing bleeding and transfusion is of fundamental clinical importance in order to rapidly address and correct the acute coagulopathy of trauma including potential triggers via early activation of damage control resuscitation (DCR) strategies, MT protocols and timely adequate mobilization of resources, for example blood bank resources in the civilian setting as well as activation of whole blood donation in the military setting (16) (17) (18) (19) .
To date, several authors have shown that early recognition of the acute coagulopathy of trauma accompanied by adequate and aggressive management including the balanced use of blood components can correct coagulopathy, control bleeding, reduce blood product use and improve outcome in severely injured patients (20) (21) (22) . However, the optimum ratio of packed red blood cell concentrates (pRBCs), fresh frozen plasma concentrates (FFPs), and platelet concentrates (PCs) is still under investigation (PROPPR: Prospective Randomized Optimum Platelet and Plasma Ratios Study). As an alternative approach, other groups have reported improved survival rates by using thromelastometry guided individualized coagulation therapy based on the administration of coagulation factor concentrates (23). But also here, no 3 A C C E P T E D randomized controlled study has been performed to date assessing this concept and safety data are still lacking. In this review we present the current understanding and concepts of the acute coagulopathy of trauma as well as clinically relevant strategies for its early detection. These concepts, in principle, are based upon the constructive discussions among key opinion leaders in the field during the 8 th Wiggers-Bernard-Conference on "Trauma-induced Coagulopathy" held in Salzburg (Austria), February 16-18, 2011 (see also Supplement to Shock xx).
The Acute Coagulopathy of Trauma
The priniciple triggers to drive the acute coagulopathy of trauma are summarized in Figure 1 (7, 24, 25) . Direct loss and the consumption of coagulation factors, dilution, hypothermia, acidosis and fibrinolysis and the release of anticoagulation factors, e.g. activated protein C, all interfere with coagulation and diminish haemostasis. There seems to be an additive effect among the clinical drivers of the process as the probability of life-threatening coagulopahy increases with the number of triggers present. Cosgriff and co-workers (26), for example, have shown that the conditional probability of developing coagulopathy after trauma was 1% in moderate injury without the presence of additional triggers but increased to 39% in severe injury (ISS > 25) combined with hypotension, to 58% when injury occurred with acidosis (pH < 7.1), and to 98% in cases of ISS > 25 together with hypotension (systolic blood pressure < 70mmHg), hypothermia (<34 o C), and acidosis (pH < 7.1).
Dilution may occur both physiologically and iatrogenically. In trauma-associated physiologic haemodilution, the unopposed osmotic activity of plasma in states of hypotension is prompted by a water shift into the intravascular space thus diluting plasma proteins until equilibrium is re-established. In this scenario each protein is diluted to the same amount and their interactions, for example the intrinsic "tenase complex" comprising combined factors IXa, VIIIa and X, are reduced proportionally to their individual factor concentrate changes. In this 4 A C C E P T E D model, Monroe calculated a 37% reduction in single factor concentration to result in a 75% reduction in overall complex activity (27).
Iatrogenic dilution is caused by unguided and often over administration of fluids in the acute phase of trauma care. In patients from the TR-DGU database (TraumaRegistry of the Deutsche Gesellschaft für Unfallchirurgie/German Trauma Society) coagulopathy upon Emergency Room (ER) admission was observed in > 40% of patients with > 2000mls, in > 50% with > 3000 mls, and in > 70% with > 4000 mls of fluids administered during the prehospital phase of care (13) . More recently, a pre-hospital intravenous colloid:crystalloid ratio ≥ 1:2 and the amount of pre-hospital intravenous fluids ≥ 3000 ml have been identified as independent contributors to the acute coagulopathy of trauma (25). This dilution is accompanied by consumption and inactivation not only of cogulation factor substrates but also coagulation enzymes with magnitudes matching the degree of individual injury (28).
Meng and co-workers have frequently demonstrated the effects of temperature and pH on coagulation factor and complex activity (29,30). Both, temperature and acidosis, contribute to coagulopathy by reducing the pace of plasma coagulation factor biochemical reactions. This 
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Under physiological conditions the coagulation system modulates fibrinolysis in that blood clots are maintained stable for a given time to control bleeding and to promote adequate wound healing. High concentrations of thrombin inhibit plasmin activation via the activation of TAFI (thrombin-activated fibrinolysis inhibitor) and PAI-1 (plasminogen activator inhibitor-1). Vice-versa, if the thrombin burst is weak, TAFI remains unactivated.
Furthermore, if thrombin encounters thrombomodulin on endothelial cells, protein C may be activated which then inactivates PAI-1.
Hyperfibrinolysis (HF) has been identified as a major contributor of mortality in bleeding trauma patients (33,34). For example, Schöchl and co-workers have reported a mortality rate of approximately 88% in trauma patients with hyperfibrinolysis present upon Emergency Room (ER) admission as detected by viscoelastic testing (33). Even a small reduction of the maximum amplitude in thromelastography (TEG > 15%) is likely to be associated with higher transfusion requirements including MT, coagulopathy and haemorrhage-related death (34).
Acute Coagulopathy in Trauma and Shock
More recently, it has been recognized that another group of trauma patients presents to the ER with early evidence of coagulopathy both physiologically and mechanistically distinct from this above referrenced traditional sytemic aquired coagulopathy. Several studies have identified an acute traumatic coagulopathy, according to standard coagulation tests, present in 25-30% of patients with major trauma without being exposed to the traditional triggers of coagulopathy. For example, Brohi and colleagues have reported a series of patients who had received < 500 mls of fluids during pre-hospital care of whom one out of four presented coagulopathic upon arrival to the trauma bay as indicated by a prothrombin time (PT) ≥ 1.5 (12) . This finding was confirmed by other investigators reporting even larger patient series (13, 14) and also in children (35). Our own group has reported the presence of coagulopathy 6 A C C E P T E D upon admission even in trauma patients who had received no fluid resuscitation at all during their pre-hospital phase of care (13) . In all studies, the presence of coaguloathy was associated with a higher magnitude of injury sustained as refleced by higher Injury Severity Scores (ISS) as well as a dramatic increase in mortality up to two-to four-fold (12) (13) (14) 35, 36) (Figure 4) . In Brohi´s study, increasing injury severity predicted a stepwise increasing fraction of patients with increased PT upon admission with presence in 45% of all patients with an ISS > 45 (12) .
Abnormalities in other conventional tests such as fibrinogen levels and platelet counts showed a similar stepwise increase together with increased injury severity (36). Among the 28% of the 20,000 trauma center admissions with any initial PT prologantion reported by MacLeod and colleagues, there was a 35% increase in the risk of in-hospital death; among the 8% of patients with prolonged partial thromboplastin time (PTT), the increase in risk of dying was 42% (14) . Noteworthy, all of these deaths occurred within the first five hours after admission and were due to uncontrolled primary haemorrhage.
In their analysis from data from the German TR-DGU database, Wafaisade and co-workers reported an ongoing state of shock after trauma (on scene and upon admission to the trauma bay) to be associated with an almost three-fold increase in risk for the development of coagulopathy (25). Figure 5 shows an increasing frequency of coagulopathy upon ER arrival with increasing levels of shock as reflected by base excess (BE). This finding corresponds to other reports (7, 15) and has also been described in children (35). Hypoperfused tissue inducing acidemia may be one potential mechnism underlying this shock/trauma-induced coagulopathy, as acidemia interferes with with the coagulation enzyme activity (see above).
More recently, several authors have shown that shock may also activate anticoagulant and hyperfibrinolytic pathways. In this context, Brohi and colleagues have suggested that, in the presence of shock and hypoperfusion, the endothelium releases thrombomodulin which complexes with thrombin to divert it into an anticoagulant function. Thus, reduced amounts of 7 A C C E P T E D thrombin are available to cleave fibrinogen, and thrombin complexed to thrombomodulin may also activate protein C which inhibits the extrinsic pathway and antifibrinolytic factors (8; Figure 6 ). Of course, this relatively new identified pathway still needs further and more detailed investigation.
Thus, direct tissue trauma and shock/hypoperfusion may represent the primary drivers responsible for the development of this distict form of coagulopathy apart and independent from the traditional factors. This coagulopathy is, in addition, associated with a higher transfusion requirement, a greater incidence of multi organ dysfunction syndrome, longer ICU and overall in-hospital length-of-stays (LOSs) as well as a four-fold increase in mortality compared to those patients with normal coagulation. The early undetected presence of this distinct coagulopathy almost certainly contributes to the development and aggravation of the above mentionned coagulopathy which is considered systemically aquired and frequently observed after severe injury.
Strategies and Tools for Early Detection and Stratification of Risk
Pertubations in blood coagulation are common after major trauma and are associated with poor outcomes. A substantial proportion of trauma patients is already coagulopathic upon admission (11) (12) (13) (14) and incidence rates up to 60% have been reported according to definition (37). The human coagulation system can be rapidly overwhelmed by severe injury (38) and death from traumatic exsanguination usually occurs early, typically within the first six to 12 hours after initial impact but heavily weighted toward the first 1-2 hours (15, (39) (40) (41) . life-threatening situations. However, the hazards of transfusion may appear somewhat trivial relative to the need of care for an exsanguinating patient.
Substantial problems in the use of conventional coagulation testing for the early identification of patients in the need for transfusion including those requiring MT include delayed turnaround times, incomplete characterization, and their poor predictive nature not accurately reflecting the patient´s true coagulation status (12, 56, 57) . Although international normalized ratio (INR) and base deficit (BD) are good predictors of mortality, by themselves, they cannot discriminate between patients to may go or not go on for MT (58). Second, surgical relevant bleeding due to thoracic and/or retro-/ intraperitoneal organ injury is difficult to detect and often requires time consuming diagnostics (59). Thus, significant haemorrhage and coagulopathy may be underestimated or even missed during early resuscitation (14, 60) .
Scoring Systems and Algorithms
Over the past few years, a considerable number of scoring systems has been developed and introduced for the initial evaluation of the bleeding trauma patient in both civilian (17, 45, (61) (62) (63) (64) (65) (66) (67) (68) (69) and military seetings (70) (71) (72) (73) . The authors have just recently published a comprehensive overview of the most commonly discussed scoring systems and algorithms for the need of transfusion including massive transfusion in severely injured patients (74) . These systems may provide clinically useful information that potentially gives freedom to providers to deviate from established algorithms toward the more aggressive and early use of blood products with the assumption that early product use improves outcome. These scoring systems may be used to guide the activation of massive transfusion protocols and could help providers of all experience levels know when it is likely that the patient will require a massive transfusion.
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The scoring systems developed to date usually suggest combinations of physiologic, haemodynamic, laboratory, injury severity and demographic triggers identified on the initial evaluation of the bleeding trauma patient. Many of them use a combination of dichotomous variables that are obtained rapidly after the patients´s arrival to the trauma bay but others rely on time-consuming mathematical calculations or complex scoring algorithms that are required to determine the patients who will need MT and may thus have limited real-time application.
The most commonly proposed triggers that were correlated with the need for transfusion including massive transfusion in the civilian setting are shown in Table 1 and include systolic blood pressure which is present in 9/9 scoring systems, followed by heart rate (present in 6/9 scoring systems), haemoglobin/haematocrit (present in 5/9 scoring systems), and positive focused assessment for the sonography of trauma (FAST+; present in 4/9 scoring systems).
Parameters that can be quickly obtained via point-of-care (POC) ABG (arterial blood gas)-analyzers, for example base excess/deficit (BE/BD), lactate, and pH are included in 6/9 civilian scoring systems. Six out of nine systems consider anatomical injury including its magnitude or mechanism of injury as component of their assessment. However, the severity of injury as reflected by the Injury Severity Score (ISS) or the overall pattern of the anatomical injury may be difficult to calculate and to assess during initial assessment. from each patient to calculate all six scores. Although we had initially attempted to validate all scores on our database, the remaining scores had to be excluded from this analysis due to missing or non-captured data within our registry for model calculation. For the TASH-Score, this analysis served again as an internal validation while all other scores were externally validated by being subjected onto our datasets. Not surprisingly that the TASH-Score performed best (AUROC 0.889) followed by the PWH-Score (AUROC 0.860) which is also a weighted score with structure and content variables very similar to the TASH-Score ( Figure   7 ). In this analysis, the non-weighted and more simple scores performed less accurate 
Viscoelastic Testing Methods
An alternative to scoring systems and algorithms to early recognize trauma-induced coagulopathy with the risk of on-going haemorrhage and transfusion requirement is the early use of viscoelastic testing methods. To date, similar to the above referenced scoring systems and algorithms prospective data is also limited for this approach. However, low maximum along with low haemoglobin levels to be an independent risk factor for massive transfusion (78) . An overview of the most relevant studies conducted to date on the use of viscoelastic testing in the context of the acute coagulopathy of trauma including main conclusions is provided in Table 2 .
Point-of-care viscoelastic testing may offer the unique potential to predict transfusion even faster as compared to scoring systems involving conventional coagulation testing and to activate and guide resusucitations more objectively. A recent retrospective analysis of major trauma patients revealed low FIBTEM amplitudes (< 4mm) and/or low EXTEM amplitudes at 10 minutes (CA 10) to be highly predictive for massive transfusion (79) 
